ACCM meeting #19, 20 March 2018

The meeting of the Advisory Committee on Complementary Medicines (ACCM).

The committee's advice was sought on:

• The association between the use of Camellia sinensis and hepatotoxicity and whether risk mitigation strategies are warranted.
• The proposed course of action in relation to environmental contaminants in some listed medicines.
• The suitability of an excipient ingredient for use in topically applied listed medicines.

Members

Membership comprises of professionals with specific scientific, medical, clinical expertise as well as appropriate consumer health issues relating to complementary medicines.